MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2021

    Effects of dopaminergic medication on reinforcement learning in Parkinson’s disease depend on depressive symptoms

    J. Tichelaar, C. Sayali, R. Helmich, R. Cools (Nijmegen, Netherlands)

    Objective: To investigate the effect of depression and dopaminergic medication on reinforcement learning (RL) in Parkinson’s disease. Background: Dopaminergic medication in PD is known to…
  • MDS Virtual Congress 2021

    Links between Cognitive Impairment and Contrast Sensitivity in Parkinson’s Disease

    C. Catiul, R. Memon, A. Memon, A. Joop, J. Pilkington, K. Wood, A. Amara (Birmingham, USA)

    Objective: To evaluate the relationship between Contrast Sensitivity (CS) and cognitive function in patients with idiopathic Parkinson’s Disease (PD) and healthy controls (HC). Background: In…
  • MDS Virtual Congress 2021

    GALLIC ACID AMELIORATES THE NEUROBEHAVIOURAL DEFICITS INDUCED BY BISPHENOL A (BPA) IN WISTAR RATS

    K. Adigun, M. Ehinmowo, A. Adebiyi, O. Adebiyi (Ibadan, Nigeria)

    Objective: Bisphenol A (BPA) has been found to exert neurotoxic effects through its neuroendocrine disruption and generation of reactive oxygen species (ROS). It can also…
  • MDS Virtual Congress 2021

    Cognitive assessment of Parkinson’s Disease patients in a Northeast Brazilian population: Current Challenges

    J. Bonfadini, D. Lima, A. Carneiro, J. Luna, A. Damasceno, P. Braga-Neto (Fortaleza, Brazil)

    Objective: To evaluate the influence of education level in the Mini-Mental Status Examination (MMSE) score in Parkinson’s Disease (PD) patients in a northeast Brazilian sample.…
  • MDS Virtual Congress 2021

    Sociodemographic, cognitive, and clinical factors explaining financial-arithmetic errors in Parkinson’s Disease

    H. Loenneker, S. Becker, S. Nussbaum, H-C. Nuerk, I. Liepelt-Scarfone (Tuebingen, Germany)

    Objective: To assess the frequency, predictors, and affected cognitive representations of arithmetic errors in financial contexts in Parkinson’s Disease (PD), patients with normal cognition (PD-NC)…
  • MDS Virtual Congress 2021

    Parkinson’s Disease, Cognitive Function and Medication Management: A Problem in Routine Care

    P. Tierney, O. Kaczmarek, A. Sethi, B. Bumstead, M. Buhse, E. Kravis, B. Anand, M. Zarif, M. Gudesblatt (Patchogue, USA)

    Objective: Explore the relationship between objective and patient-reported assessment of cognition to patient-reported medication management capabilities. Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder…
  • MDS Virtual Congress 2021

    Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease; role for cholinergic transmission?

    R. Cerroni, A. Viziano, A. Stefani, R. Sisto (Rome, Italy)

    Objective: To understand to what extent an early cochlear dysfunction may represent an additional non-motor signature of Parkinson’s disease (PD) patients. Further, whether it may…
  • MDS Virtual Congress 2021

    Does Macronutrient dietary Intake of patients with Parkinson disease correlates with the cognitive function (MoCA)?

    C. López Botello, S. Castillo Torres, I. Estrada Bellmann, B. Chávez Luevanos (Monterrey, Mexico)

    Objective: Analyze the correlation between macronutrient dietary intake and cognitive function of patients with Parkinson’s Disease Background: Several studies have shown that implementing a healthy…
  • MDS Virtual Congress 2021

    ASSOCIATION BETWEEN INSULIN RESISTANCE AND DEVELOPMENT OF DEMENTIA IN PATIENTS WITH PARKINSON´S DISEASE

    C. Borrue-Fernandez, E. Ferriz (San Sebastian Reyes, Spain)

    Objective: The main objective of the study was to analyze the association between insulin resistance (IR ) at  diagnosis and the development of dementia in…
  • MDS Virtual Congress 2021

    Cognitive Diagnostics for Parkinson’s Disease: A Novel Digitized Approach Using Non-Motor Symptoms

    A. Murrar, M. Abu Snineh, M. Herzallah (Jerusalemp, State of Palestine)

    Objective: To evaluate the validity and reliability of cognitive markers to identify patients with PD Background: Parkinson’s disease (PD) is classically diagnosed by the clinical…
  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley